The Cardiovascular disease market, which includes various numbers of disorders like hypertension, coronary artery disorders, cardiac arrest, dyslipidaemia and thrombotic events is set to grow from $129.2 billion in 2015 to $146.4 billion by 2022, at a very modest compound annual growth rate of 1.8%, according to business intelligence provider GBI Research. The Global Cardiology market size was valued at USD 116.9 billion in 2017 and is expected to grow at a CAGR of 7.4% over the determined forecast period 2017-2022. These statistics include information on essential health behaviors (smoking, physical activity, diet, and weight) as well as factors (such as cholesterol, vital signs, and glucose control) that effect cardiovascular health.
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
